Full-Time

Research Director Program Lead

Quantitative Research

Updated on 9/4/2026

Inizio

Inizio

5,001-10,000 employees

Guides clinical development and commercialization

No salary listed

London, UK

Hybrid

Hybrid schedule: two days per week at the central London office, or UK remote work with one office day per month.

Category
Consulting (1)
Required Skills
Market Research
Data Visualization
Quantitative Research
Risk Management
Data Analysis

Get referred to Inizio

See people who can refer or advise you

Requirements
  • Significant senior-level experience in primary quantitative market research, specialized within healthcare or life sciences.
  • A strong track record leading large, complex, multi-market quantitative tracking, awareness, trial and usage, or syndicated programs across multiple waves and parallel workstreams.
  • Strong research and analytical credibility, including the ability to understand and challenge questionnaire design, sampling, key performance indicator frameworks, analysis, interpretation, and reporting; this is not a pure project management role.
  • Demonstrated ability to lead cross-functional, geographically dispersed teams and influence senior stakeholders without relying on formal line authority.
  • Substantial experience managing senior client relationships throughout the lifecycle of a program, including central and brand or therapy-area stakeholders.
  • Excellent program planning and governance capability, including risk, issue, dependency, decision, scope, and change management.
  • A proactive and structured approach to problem-solving, with evidence of intervening early and leading complex issues through to resolution.
  • Experience of dashboard or automated reporting deliverables and a strong interest in advanced analytics, automation, and artificial-intelligence-enabled insight generation.
  • Experience collaborating across geographies and with offshore or specialist delivery teams.
  • Commercial awareness, including the ability to protect scope, recognize change, support program sustainability, and identify opportunities to add value.
  • Clear, confident communication and facilitation skills, with the ability to make complex topics understandable and drive decisions.
Responsibilities
  • Own the program plan, governance, and delivery across concurrent waves, therapy areas, and markets, translating the program vision into clear priorities, owners, and deadlines.
  • Maintain oversight of progress, risks, and opportunities; intervene early and escalate material issues with clear recommendations.
  • Make timely program decisions, balancing client priorities, research integrity, operational constraints, and commercial considerations.
  • Build program resilience through effective documentation, knowledge sharing, and succession planning.
  • Lead, coordinate, and hold accountable the research, operations, data, analytics, and dashboard teams that contribute to the program, mobilizing the right expertise at the right time and creating a collaborative one-team culture.
  • Act as the key day-to-day contact for the central client team, building trusted relationships and translating strategic and business needs into program priorities.
  • Communicate progress, risks, decisions, and trade-offs clearly, working with program and commercial leadership to manage expectations, scope, and change.
  • Ensure client objectives are reflected consistently from research design and data collection through to analysis, interpretation, and reporting.
  • Protect quality and comparability across waves, markets, and therapy areas while enabling justified adaptation and drawing on specialist expertise where required.
  • Drive timely, quality-assured, and compliant delivery, proactively resolving issues before they affect the client and embedding preventative actions.
  • Identify and implement improvements in processes, automation, analytics, and reporting that increase efficiency, quality, and client value.
  • Lead the identification, evaluation, and implementation of innovations in automation, artificial intelligence, analytics, and reporting that improve client value, program efficiency, and scalability.
  • Provide clear direction, priorities, and coaching to the program team, reinforcing high standards and visible ownership.
  • Lead onboarding and training so that teams understand the program design, analytical framework, and agreed ways of working.
Desired Qualifications
  • Experience leading a large-scale global program for a major pharmaceutical client.
  • Experience of programs that combine shared global standards with market- or therapy-area-specific requirements.
  • Exposure to dashboard development, advanced analytics, automation, or artificial-intelligence-enabled market research solutions.
  • Experience contributing to program transformation, renewal, or expansion.

Inizio helps health and life sciences companies develop and commercialize products to maximize patient access. It uses a connected suite of capabilities and expert guidance to navigate assets through their entire lifecycle with tailored strategies. Unlike firms that offer single services, Inizio combines multiple capabilities in an end-to-end approach focused on reducing complexity and ensuring lifecycle support. Its goal is to bring therapies to patients faster and more effectively by coordinating development, regulatory, market access, and commercialization activities to maximize value and treatment outcomes.

Company Size

5,001-10,000

Company Stage

N/A

Total Funding

N/A

Headquarters

New York City, New York

Founded

N/A

Get referred to Inizio

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Inizio launched Connected Insights on July 28, 2026, expanding APAC medical-information services.
  • On May 12, 2026, Intelligent Congress added measurable analytics to a high-spend commercial offering.
  • Hub Services launched April 23, 2026, strengthening patient access, reimbursement, and adherence programs.

What critics are saying

  • The 2025 annual report showed a $16.7 million restructuring charge and workforce streamlining.
  • Headcount fell from 10,872 in 2023 to 10,004 by March 2026.
  • Big pharma clients can consolidate vendors or insource services, crushing Inizio's outsourced margin base.

What makes Inizio unique

  • Inizio serves 100% of top 20 pharma across 50 countries and 175 congresses yearly.
  • Its integrated model spans medical affairs, congresses, patient access, and commercialization execution.
  • Inizio embeds AI across workflows, from voice analytics to virtual agents and training personas.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

Performance Bonus

Professional Development Budget

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

5%

1 year growth

5%

2 year growth

7%
PR Newswire
Jul 28th, 2026
Inizio launches AI-enabled Connected Insights to transform medical information into strategic intelligence

Inizio has expanded its Global Medical Information capabilities through Inizio Engage, launching Connected Insights to help pharmaceutical and biotechnology companies transform medical information into strategic intelligence. The service combines expanded Asia-Pacific expertise, enhanced global infrastructure, and AI-enabled innovation. The company supports more than one million medical information interactions annually across 500+ products in 55+ global programmes, delivering services in over 20 languages. AI-powered features have increased training simulations tenfold and improved training success by 50%. The expansion includes continued growth across the APAC region, expanded global infrastructure, and AI-enabled innovations throughout the medical information workflow, including AI-powered training personas, speech analytics, and virtual agents. The investment reinforces Inizio's commitment to connecting scientific expertise with technology and data-driven insight across the product lifecycle.

PR Newswire
May 12th, 2026
Inizio launches Intelligent Congress solution to measure medical event impact

Inizio, a global commercialisation partner to health and life sciences companies, has launched Intelligent Congress, an end-to-end solution designed to maximise the value of medical congress investments and deliver measurable business impact. The platform addresses fragmented planning and unclear objectives that often dilute congress opportunities. It integrates strategy, experience design, delivery and measurement across the full congress lifecycle, enabling clients to focus on meaningful shifts in healthcare professional engagement and behaviour rather than isolated metrics. Intelligent Congress uses a four-step framework spanning the entire congress calendar, capturing real-time insights and evaluating impact against key datasets. Inizio has supported over 80 clients across 27 countries, facilitating more than 1,000 healthcare professional engagements and managing over 25,500 attendees.

PR Newswire
Apr 23rd, 2026
Inizio launches integrated hub services combining analytics, pharmacy and specialist support to improve patient access

Inizio has launched its fully integrated Hub Services through its Inizio Engage business unit, targeting improved patient access, reimbursement and adherence for life sciences companies. The solution combines advanced analytics, pharmacy capabilities and specialised expertise to streamline the patient journey. The offering includes non-dispensing pharmacy services for benefit verification and fulfilment coordination, comprehensive access and reimbursement support, field reimbursement services and non-commercial dispensing pharmacy. Advanced analytics predict potential delays before they occur. Inizio Engage, which employs over 6,000 experts across 20 countries and delivers over 5 million engagements annually, will showcase the service at the Asembia Summit in Las Vegas from 27–30 April 2026. The company has made significant investments in leadership across patient access, pharmacy, reimbursement and analytics to support the service.

PR Newswire
Feb 6th, 2025
Inizio Accelerates Growth With A Trio Of Strategic Leadership Appointments

LONDON, Feb. 6, 2025 /PRNewswire/ -- Inizio, a commercialization partner for health and life science companies, has today announced the appointment of Colin Stanley as Chief Commercial Officer (CCO), Remco op den Kelder as President of Inizio Advisory and Jim Sage as President of Inizio Engage.Stepping into the CCO role, Colin brings over 25 years of sector experience and a proven track record in business growth in the industry, from CRO and commercialization

Bio-IT World
Oct 20th, 2024
Inizio Medical Appoints Patrick Giordani as SVP, AI Solutions Architect, Underpinning Commitment to Expanding AI Capabilities and Accelerating Innovation

Inizio Medical, the leading provider of Medical Affairs and communications solutions, today announced the appointment of Patrick Giordani as Senior Vice President, AI Solutions Architect.